Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Healthcare and Social Assistance

>>

Business Opportunities and Investment Strategies for Global Parenteral Nutrition Market


Business Opportunities and Investment Strategies for Global Parenteral Nutrition Market 2023-2033

Report code: SDMRHE1703177 | Industry: Healthcare and Social Assistance | Published On: 2024-05-14


Opportunity and Strategy Analysis
This report focuses on identifying opportunities and strategies for investing in the global parenteral nutrition market within the forecast period. It provides a complete analysis of the global market both quantitatively and qualitatively. The quantitative analysis includes market size and revenue data of the total demand, sub-markets, and regional/national levels throughout 2023-2033. Qualitative analysis depicts a full picture of market dynamics and trends including drivers, restraints and challenges, emerging products/market trends, and Porter’s Fiver Forces analysis.

Based on the market data and analysis, the report highlights Increasingly Attractive Segments (IAS) and business opportunities in each segmentation. Moreover, a systematic evaluation of Internal Risks (factors arising within the industry development) and External Risks (factors arising from the surrounding environments) is provided for the parenteral nutrition industry and market. All the identified risk factors are measured quantitatively according to GMD’s novel numeric system, i.e. each risk is evaluated with GMD Risk Index Number (GMD RIN) and GMD Risk Intensity Level (GMD RIL). This in-depth risk assessment offers a comprehensive understanding of the current risk factors and their developing trends. Furthermore, this report concludes risk management strategies and Critical Success Factors (CSFs) to help companies make intelligence-based business decisions in the global parenteral nutrition industry.

Market Coverage & Overview
The report is based on studies for 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. Considering impact of COVID-19 and regional conflicts such as Russia-Ukraine war, the trend and outlook of global market is forecast in optimistic, balanced, and conservative scenarios. In the balanced view, the global parenteral nutrition market is expected to reach $14.85 billion by 2033, growing by 7.1% annually over the coming years.

Segmentation Analysis
Highlighted with 90 tables and 104 figures, this 199-page report represents a 360-degree view on the global market with extensively detailed segmentations by Nutrient Type, Dosage Form, Indication, Patient Group, End User, Distribution Channel, and Region/Country as shown below. Annual revenue 2023-2033 for each segment is included in the report.

By Nutrient Type
• Amino Acids
• Carbohydrates
• Trace Elements
• Lipid Emulsion
• Vitamins and Minerals
• Other Nutrient Types

By Dosage Form
• Ampules
• Bags
• Bottles
• Vials

By Indication
• Short-Term
• Long-Term

By Patient Group
• Pediatric Patients
• Adult Patients
• Geriatric Patients

By End User
• Hospitals
• Clinics & Ambulatory Care Settings
• Homecare
• Other End Users

By Distribution Channel
• Retail Stores
• Pharmacies & Drug Stores
• Online Channels
• Other Distribution Channels

By Region
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (Turkey, Saudi Arabia, South Africa, and Rest of MEA)
The breakdown of all regional markets by country and the breakdown of each national market by Nutrient Type, Patient Group, and End User over the forecast years are also included.

Key Companies
The report also covers the current competitive scenario and profiles key vendors including market leaders and important emerging players. A selection of companies profiled in this report includes:
• AbbVie Inc.
• Aculife Healthcare Private Limited
• Albert David Limited
• Amanta Healthcare Ltd.
• American Regent Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• BML Parenteral Drugs
• Claris Lifesciences Limited
• Eurofarma
• EuroLife Healthcare Pvt. Ltd.
• Farmoterapica
• Fresenius Kabi AG
• Grifols S.A.
• ICU Medical Inc.
• JW Pharmaceuticals
• Otsuka Pharmaceutical Factory Inc.
• Pfizer Inc.
• REVIV
• Sichuan Kelun Pharmaceutical Co., Ltd.
• Soleo Health
• Vifor Pharma Management Ltd.

1  Introduction 10
1.1  Industry  Definition  and  Research  Scope 10
1.1.1  Industry  Definition 10
1.1.2  Research  Scope 11
1.2  Research  Methodology 14
1.2.1  Overview  of  Market  Research  Methodology 14
1.2.2  Market  Assumption 15
1.2.3  Secondary  Data 15
1.2.4  Primary  Data 15
1.2.5  Data  Filtration  and  Model  Design 16
1.2.6  Market  Size/Share  Estimation 17
1.2.7  Research  Limitations 18
1.3  Executive  Summary 19
2  Market  Overview  and  Dynamics 22
2.1  Market  Size  and  Forecast 22
2.1.1  Impact  of  COVID-19  on  World  Economy 23
2.1.2  Impact  of  COVID-19  on  the  Market 27
2.1.3  Impact  of  Russia-Ukraine  Conflict 29
2.1.4  Impact  of  Israel-Palestine  War 31
2.2  Major  Growth  Drivers 32
2.3  Market  Restraints  and  Challenges 38
2.4  Emerging  Opportunities  and  Market  Trends 41
2.5  Porter’s  Fiver  Forces  Analysis 44
3  Segmentation  of  Global  Market  by  Nutrient  Type 48
3.1  Market  Overview  by  Nutrient  Type 48
3.2  Amino  Acids 51
3.3  Carbohydrates 52
3.4  Trace  Elements 53
3.5  Lipid  Emulsion 54
3.6  Vitamins  and  Minerals 55
3.7  Other  Nutrient  Types 56
4  Segmentation  of  Global  Market  by  Dosage  Form 57
4.1  Market  Overview  by  Dosage  Form 57
4.2  Ampules 60
4.3  Bags 61
4.4  Bottles 62
4.5  Vials 63
5  Segmentation  of  Global  Market  by  Indication 64
5.1  Market  Overview  by  Indication 64
5.2  Short-Term 67
5.3  Long-Term 68
6  Segmentation  of  Global  Market  by  Patient  Group 69
6.1  Market  Overview  by  Patient  Group 69
6.2  Pediatric  Patients 72
6.3  Adult  Patients 73
6.4  Geriatric  Patients 74
7  Segmentation  of  Global  Market  by  End  User 75
7.1  Market  Overview  by  End  User 75
7.2  Hospitals 78
7.3  Clinics  &  Ambulatory  Care  Settings 79
7.4  Homecare 80
7.5  Other  End  Users 81
8  Segmentation  of  Global  Market  by  Distribution  Channel 82
8.1  Market  Overview  by  Distribution  Channel 82
8.2  Retail  Stores 85
8.3  Pharmacies  &  Drug  Stores 86
8.4  Online  Channels 87
8.5  Other  Distribution  Channels 88
9  Segmentation  of  Global  Market  by  Region 89
9.1  Geographic  Market  Overview  2023-2033 89
9.2  North  America  Market  2023-2033  by  Country 94
9.2.1  Overview  of  North  America  Market 94
9.2.2  U.S. 98
9.2.3  Canada 101
9.2.4  Mexico 103
9.3  European  Market  2023-2033  by  Country 105
9.3.1  Overview  of  European  Market 105
9.3.2  Germany 109
9.3.3  U.K. 111
9.3.4  France 113
9.3.5  Spain 115
9.3.6  Italy 117
9.3.7  Russia 119
9.3.8  Rest  of  European  Market 121
9.4  Asia-Pacific  Market  2023-2033  by  Country 123
9.4.1  Overview  of  Asia-Pacific  Market 123
9.4.2  Japan 127
9.4.3  China 130
9.4.4  Australia 132
9.4.5  India 134
9.4.6  South  Korea 136
9.4.7  Rest  of  APAC  Region 138
9.5  South  America  Market  2023-2033  by  Country 140
9.5.1  Argentina 144
9.5.2  Brazil 146
9.5.3  Chile 148
9.5.4  Rest  of  South  America  Market 150
9.6  MEA  Market  2023-2033  by  Country 151
9.6.1  Turkey 155
9.6.2  Saudi  Arabia 157
9.6.3  South  Africa 159
9.6.4  Other  National  Markets 161
10  Competitive  Landscape 162
10.1  Overview  of  Key  Vendors 162
10.2  New  Product  Launch,  Partnership,  Investment,  and  M&A 166
10.3  Company  Profiles 167
AbbVie  Inc. 167
Aculife  Healthcare  Private  Limited 169
Albert  David  Limited 170
Amanta  Healthcare  Ltd. 171
American  Regent  Inc. 172
B.  Braun  Melsungen  AG 173
Baxter  International  Inc. 174
BML  Parenteral  Drugs 175
Claris  Lifesciences  Limited 176
Eurofarma 177
EuroLife  Healthcare  Pvt.  Ltd. 178
Farmoterapica 179
Fresenius  Kabi  AG 180
Grifols  S.A. 181
ICU  Medical  Inc. 182
JW  Pharmaceuticals 183
Otsuka  Pharmaceutical  Factory  Inc. 184
Pfizer  Inc. 185
REVIV 186
Sichuan  Kelun  Pharmaceutical  Co.,  Ltd. 187
Soleo  Health 188
Vifor  Pharma  Management  Ltd. 189
11  Investing  in  Parenteral  Nutrition  Industry:  Risk  Assessment  and  Management 190
11.1  Risk  Evaluation  of  Global  Market 190
11.2  Critical  Success  Factors  (CSFs) 196
RELATED  REPORTS 199
To know more, kindly contact [email protected]
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT